Paper I
2018 July (Supplementary) (2010 Scheme) · 40 marks · 120 min

Question

Rationale for use of dantrolene sodium in malignant hypertension

Q81 marksShort Answers

Answer

Dantrolene sodium acts directly on skeletal muscle. It binds to the ryanodine receptor (RyR1) on the sarcoplasmic reticulum, inhibiting calcium release into the myoplasm. This reduces excitation-contraction coupling and skeletal muscle rigidity/contraction, which is the specific treatment for malignant hyperthermia (an inherited hypermetabolic reaction to certain anaesthetic agents like halothane/succinylcholine, causing muscle rigidity, hyperthermia, and metabolic acidosis).

Other Years Asked


Revise MBBS
Preview